Indian exec gets five years for fakes-making; AZ workers return to picket line;

> A director of Indian pharma company Axon Labs has earned five years in jail for manufacturing phony Sapagun tablets. Article

> The Canadian Pharmaceutical Distribution Network has joined GHX, the Global Healthcare Exchange, to enhance connectivity with its hospital clients. CPDN release

> Drug formulator Bend Research will work with Quotient Clinical to develop compounds for clinical trials and expand options for drug delivery. Bend release

> Ghana has uncovered substandard and counterfeit versions of 13 antimalarial medicines across the country. Story

> Medicago has earned an IRS grant for development work on a Virus-Like Particle vaccine. Medicago release

> AstraZeneca workers in the U.K. are set to return to the picket line. News

> A cut in the value of a Minnesota manufacturing facility and the delay of its sale have had little impact on Genmab, which reported reduced operating losses. Report

> A 15 percent rise in pharma output contributed to a third-quarter boost in Ireland's manufacturing production. Story

> Startup Gallus Biopharmaceuticals plans to buy and expand Johnson & Johnson's Centocor Biologics campus in St. Louis. Article

> Thermo Fisher Scientific has added a 2,000-liter single-use bioreactor to its HyClone line. TFS release

> Tate & Lyle will produce farnesene at its facilities in Decatur, IL, for Amyris. Amyris release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.